Therefore, a better understanding of the mechanism by which cytoglobin protects cells from oxidative stress will result in novel targets for enhancing sensitivity and apoptosis signalling in cells to increase the effectiveness of cisplatin and other drugs in order to improve the outcome of existing treatments for cancers, including HNSCC. This evidence concerns the gene CYGB and cancer.